DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection

Journal of Virology

Volumn 69, Issue 4, 1995, Pages 2684-2688

  Yokoyama, Masayuki ^a   Zhang, Jie ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; PLASMID DNA; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; IMMUNIZATION; INFECTION PREVENTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS MENINGITIS;

EID: 0028968744     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.4.2684-2688.1995     Document Type: Article

References (31)

1. Battegay, M., S. Oehen, M. Schulz, H. Hengartner, and R. M. Zinkernagel. 1992. Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. J. Virol. 66:1199-1201.
2. Bishop, D. H. L., and D. D. Auperin. 1987. Arenavirus gene structure and organization, p. 5-17. In M. B. A. Oldstone (ed.), Current topics in microbiology and immunology, vol. 133. Arenaviruses: genes, proteins and expression. Springer-Verlag, New York.
3. Buchmeier, M. J., and M. B. A. Oldstone. 1979. Protein structure of lymphocytic choriomeningitis virus: evidence for a cell associated precursor of the virion glycopeptides. Virology 99:111-120.
4. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847-1851.
5. del Val, M., H. J. Schlicht, H. Volkmer, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 1991. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:3641-3646.
6. Eisenbraun, M. D., D. H. Fuller, and J. R. Haynes. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791-797.
7. Furth, P. A., L. Hennighausen, C. Baker, B. Beatty, and R. Woychick. 1991. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19:6205-6208.
8. Fynan, E. F., H. L. Robinson, and R. G. Webster. 1993. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12:785-789.
9. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
10. Geissler, E. K., J. Wang, J. H. J. Fechner, W. J. Burlingham, and S. J. Knechtle. 1994. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J. Immunol. 152:413-421.
11. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D. H. L. Bishop, H. Overton, and R. M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19:417-424.
12. Kägi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (London) 369:31-37.
13. Klavinskis, L. S., M. B. A. Oldstone, and J. L. Whitton. 1989. Designing vaccines to induce cytotoxic T lymphocytes: protection from lethal viral infection, p. 485-489. In F. Brown, R. Chanock, H. Ginsberg, and R. Lerner (ed.), Vaccines 89. Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Klavinskis, L. S., J. L. Whitton, and M. B. A. Oldstone. 1989. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 63:4311-4316.
15. Leibiger, B., I. Leibiger, D. Sarrach, and H. Zuhlke. 1991. Expression of exogenous DNA in rat liver cells after liposome-mediated transfection in vivo. Biochem. Biophys. Res. Commun. 174:1223-1231.
16. Lin, H., M. S. Parmacek, G. Morle, S. Bolling, and J. M. Leiden. 1990. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82:2217-2221.
17. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. de la Torre, T. A. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372-4378.
18. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11:957-960.
19. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991-993.
20. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature (London) 356:152-154.
21. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
22. Whitton, J. L. 1990. Lymphocytic choriomeningitis virus CTL. Semin. Virol. 1:257-262.
23. Whitton, J. L. 1994. The use of minigenes in antiviral vaccination, p. 429-438. In G. P. Talwar, K. V. S. Rao, and V. S. Chauhan (ed.), Recombinant and synthetic vaccines. Narosa Publishing House, New Delhi, India.
24. Whitton, J. L., N. Sheng, M. B. A. Oldstone, and T. A. McKee. 1993. A "string-of-beads"vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348-352.
25. Whitton, J. L., P. J. Southern, and M. B. A. Oldstone. 1988. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162:321-327.
26. Whitton, J. L., A. Tishon, H. Lewicki, J. R. Gebhard, T. Cook, M. S. Salvato, E. Joly, and M. B. A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303-4310.
27. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
28. Wolff, J. A., P. Williams, G. Acsadi, S. Jiao, A. Jani, and W. Chong. 1991. Conditions affecting direct gene transfer into rodent muscle in vivo. BioTechniques 11:474-485.
29. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132-140.
30. Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki, and S. H. Gromkowski. 1993. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:771-776.
31. Zhu, N., D. Liggitt, Y. Liu, and R. Debs. 1993. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211.